novel transcript, antisense to SLC32A1

“Novel transcript, antisense to SLC32A1” (ENSG00000301653) refers to a putative non-coding RNA created by transcription from the DNA strand opposite the SLC32A1 gene, which encodes a vesicular inhibitory amino acid transporter. This antisense transcript is not validated as a functional gene, lacks experimental or clinical significance, and is not recognized as a standard biological or therapeutic target. Its designation as a gene or potential target is questionable due to insufficient characterization, unclear biological relevance, and lack of supporting literature. There are currently no aliases, molecular families, biological or disease roles, drugs, mechanisms, biomarkers, or safety concerns associated with this transcript. This target name appears to be either erroneous, provisional, or missing critical annotation.\n\nIf further structured or functional information becomes available, these entries may be updated; currently, this target yields mostly null results for established biological and pharmacological categories.